Literature DB >> 21456018

Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in Dark Agouti rat.

Csaba Adori1, Rómeó D Andó, Mária Szekeres, Lise Gutknecht, Gábor G Kovács, László Hunyady, Klaus-Peter Lesch, György Bagdy.   

Abstract

3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is a popular party drug known to cause selective serotonergic damage. Here we examined the long-term recovery and aging of serotonergic fibers and levels of brain-derived neurotrophic factor (BDNF) after intermittent MDMA administration (15 mg kg(-1) i.p. every 7th day for 4 weeks, MDMA ×4) and a single-dose treatment (15 mg kg(-1) i.p., MDMA ×1) in adolescent/young adult male Dark Agouti rats. After MDMA treatment, tryptophan hydroxylase-immunoreactive fiber density decreased and then recovered in all brain regions. Recovery was more pronounced in the MDMA ×4 group compared with the MDMA ×1 group, but similar long-term BDNF responses were found after both treatments. Twenty-two months after treatment, there were fewer clusters of aberrant serotonergic fibers in the parietal cortex in the MDMA ×4 group compared with the MDMA ×1 group. There was no difference in the density of microglial cells or astrocytes in treated groups versus the control 22 months after the treatments. These results indicate that recovery of serotonergic fibers is faster after intermittent MDMA treatment than after single-dose administration, and differences in BDNF levels per se are unlikely to account for this difference. Moreover, it seems that intermittent MDMA treatment attenuates the morphological signs of aging in serotonergic fibers. In addition, neither intermittent nor single-dose MDMA exposition of young animals induces accelerated aging processes or neurodegeneration in senescence, as indicated by the unaltered densities of microglial cells and astrocytes in the treated groups compared with the control.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21456018     DOI: 10.1002/cne.22631

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  7 in total

Review 1.  MDMA for the treatment of mood disorder: all talk no substance?

Authors:  Rachel Patel; Daniel Titheradge
Journal:  Ther Adv Psychopharmacol       Date:  2015-06

2.  Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Authors:  John J D Turner; Andrew C Parrott; Julia Goodwin; Derek G Moore; Sarah Fulton; Meeyoung O Min; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2013-12-10       Impact factor: 4.153

3.  Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.

Authors:  Susan Schenk; Blaine Abraham; Dane Aronsen; Joyce Colussi-Mas; Jennifer Do
Journal:  Psychopharmacology (Berl)       Date:  2013-01-25       Impact factor: 4.530

4.  Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging.

Authors:  Abris Gilvesy; Evelina Husen; Zsofia Magloczky; Orsolya Mihaly; Tibor Hortobágyi; Shigeaki Kanatani; Helmut Heinsen; Nicolas Renier; Tomas Hökfelt; Jan Mulder; Mathias Uhlen; Gabor G Kovacs; Csaba Adori
Journal:  Acta Neuropathol       Date:  2022-08-30       Impact factor: 15.887

5.  Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging.

Authors:  Csaba Adori; Teresa Daraio; Raoul Kuiper; Swapnali Barde; Lubica Horvathova; Takashi Yoshitake; Robert Ihnatko; Ismael Valladolid-Acebes; Pauline Vercruysse; Ashley M Wellendorf; Roberto Gramignoli; Bela Bozoky; Jan Kehr; Elvar Theodorsson; Jose A Cancelas; Boris Mravec; Carl Jorns; Ewa Ellis; Jan Mulder; Mathias Uhlén; Christina Bark; Tomas Hökfelt
Journal:  Sci Adv       Date:  2021-07-21       Impact factor: 14.136

6.  Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT.

Authors:  Kuo-Hsing Ma; Tsung-Ta Liu; Shao-Ju Weng; Chien-Fu F Chen; Yuahn-Sieh Huang; Sheau-Huei Chueh; Mei-Hsiu Liao; Kang-Wei Chang; Chi-Chang Sung; Te-Hung Hsu; Wen-Sheng Huang; Cheng-Yi Cheng
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

7.  Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats.

Authors:  Peter Petschner; Viola Tamasi; Csaba Adori; Eszter Kirilly; Romeo D Ando; Laszlo Tothfalusi; Gyorgy Bagdy
Journal:  BMC Genomics       Date:  2018-08-02       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.